These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26331401)

  • 1. [Mitomycin extravasation after postoperative instillation].
    Panach-Navarrete J; Ferrandis-Cortés C; Sales-Maicas MÁ; Martínez-Jabaloyas JM
    Arch Esp Urol; 2015 Sep; 68(7):633-6. PubMed ID: 26331401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual complication after immediate postoperative intravesical mitomycin C instillation.
    Nieuwenhuijzen JA; Bex A; Horenblas S
    Eur Urol; 2003 Jun; 43(6):711-2. PubMed ID: 12767376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bladder necrosis after an immediate post-operative mitomycin C instillation].
    Branchereau J; Luyckx F; Hitier M; Karam G; Bouchot O; Rigaud J
    Prog Urol; 2011 Feb; 21(2):151-3. PubMed ID: 21296285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed healing at transurethral resection of bladder tumour sites after immediate postoperative mitomycin C instillation.
    Aagaard MF; Mogensen K; Hermann GG
    Scand J Urol; 2014 Apr; 48(2):222-4. PubMed ID: 23870006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.
    Racioppi M; Porreca A; Foschi N; Delicato G; Destito A; D'Addessi A
    Urol Int; 2005; 75(4):373-5. PubMed ID: 16327311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C.
    Stoehr B; Mueller T; Granig T; Zangerl F; Steiner H
    BJU Int; 2008 Dec; 102(11):1556-9. PubMed ID: 18691179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early postoperative mitomycin C instillation: when and how?].
    Traxer O; Gattegno B
    Prog Urol; 2004 Apr; 14(2):249-51. PubMed ID: 15217151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor.
    Maeda T; Kikuchi E; Matsumoto K; Miyajima A; Oya M
    J Urol; 2011 Mar; 185(3):802-6. PubMed ID: 21239010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
    Okumura A; Oishi N; Kaji K; Imamura T; Fuse H
    J Dermatol; 2009 Jul; 36(7):419-22. PubMed ID: 19583691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe?
    Oddens JR; van der Meijden AP; Sylvester R
    Eur Urol; 2004 Sep; 46(3):336-8. PubMed ID: 15306104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder].
    Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J
    An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.
    Shapiro O; Jones K; Wang C; Landas S; Haas GP
    Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?
    Kiss B; Schneider S; Thalmann GN; Roth B
    Int J Urol; 2015 Feb; 22(2):158-62. PubMed ID: 25339291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for good practice of intravesical instillations of BCG and mitomycin C from the French national cancer committee (CC-AFU) for non-muscle invasive bladder cancer].
    Rouprêt M; Neuzillet Y; Larré S; Pignot G; Coloby P; Rébillard X; Mongiat-Artus P; Chartier-Kastler E; Soulié M; Pfister C;
    Prog Urol; 2012 Nov; 22(15):920-31. PubMed ID: 23102014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destruction of the bladder by single dose Mitomycin C for low-stage transitional cell carcinoma (TCC)--avoidance, recognition, management and consent.
    Elmamoun MH; Christmas TJ; Woodhouse CR
    BJU Int; 2014 May; 113(5b):E34-8. PubMed ID: 24053461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing medical staff safety by using a closed system for intravesical instillation of mitomycin C.
    Haifler M; Lang E; Sabler I; Gutman Y; Lindner A; Zisman A
    Urology; 2010 Sep; 76(3):649-51. PubMed ID: 20493518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant!
    Fazlioglu A; Tandogdu Z; Kurtulus FO; Parlakkilic O; Cek M
    Urol Int; 2009; 83(3):362-3. PubMed ID: 19829042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.
    Solsona E; Iborra I; Ricós JV; Monrós JL; Casanova J; Dumont R
    J Urol; 1999 Apr; 161(4):1120-3. PubMed ID: 10081851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic cystitis following immediate post-resection intravesical instillation of mitomycin-C.
    Caso J; Qin D; Sexton WJ
    Can J Urol; 2010 Jun; 17(3):5223-5. PubMed ID: 20566021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.